News

News & Events

This page offers news and relevant information on Cilian.

 

01.02.2017 mAbs
Cilian publishes article in mAbs.
“Antibody production using a ciliate generates unusual antibody glycoforms displaying enhanced cell-killing activity.”
open press release (English)
open journal article (English)
» www.bionity.com

 

20.11.2016 European Journal of Gastroenterology & Hepatology
Cilian publiziert Artikel in European Journal of Gastroenterology & Hepatology.
“Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.”
Pressemitteilung öffnen (deutsch)

 

20.11.2016 European Journal of Gastroenterology & Hepatology
Cilian publishes article in European Journal of Gastroenterology & Hepatology.
“Novel ciliate lipases for enzyme replacement during exocrine pancreatic insufficiency.”
open press release (English)

 

11.07.2016 Press release
Cilian provides update on veterinary vaccine program
open press release (English)

 

21.06.2016 Press release
Cilian AG announced that a patent for its MAb production technology have been issued by the European Patent Office.
open press release (English)

 

17.12.2015 Press release
CILIAN AG reports positive in vivo results for its seasonal sub-unit flu vaccine, CiFlu®. Immunogenicity studies were conducted in non-human primates tested at the facilities of CILIAN’s ADITEC partners in France.
open press release (English)

 

30.03.2014 Press release
Cilian awarded a grant and became an affiliated member of the European collaborative research programme Advanced Immunization Technologies (ADITEC). Within the consortium Cilian intends to improve efficacy of its own seasonal influenza subunit vaccine CiFlu® using novel and powerful immunization technologies.
open press release (English)
» www.aditecproject.eu

 

30.01.2014 PLOS ONE
Cilian publishes article in PLOS ONE.
“A novel malaria vaccine candidate antigen expressed in Tetrahymena thermophila.”
open press release (English)
open article (English)
» open article on PLOS ONE website (English)

 

20.01.2014 Pharma Mirror Magazine
Interview with founder and CSO, Marcus Hartmann about Cilian’s recombinant influenza vaccines candidate
» open external online article of the world leading free access professional pharmaceutical magazine

 

October, 2013 Ispectrum Magazine
Issue September-October 2013
Report about Cilian’s flu vaccine candidate
“Innovative flu vaccine takes first hurdle at regulatory agency”
» open external online article (English language) of Ispectrum Magazine #03 on page 11-16
open journal article (English language)

 

11.01.2013 Press release
CILIAN is pursuing its sub-unit vaccine concept for application in the veterinary field.
open press release (English)

 

29.10.2012 Press release
CILIAN and PROINNOVERA collaborate in clinical development of a novel flu vaccine. Both companies are working to resolve manufacturing challenges associated with flu vaccines.
open press release (English)

 

 01.08.2012 Press release
Cilian AG has been granted within the frame of a consortium € 1 million for the development of its proprietary enzyme preparation Cilase® directed against exocrine pancreatic insufficiency.
open press release (English)

 

25.06.2012 Press release
Cilian AG granted US Patent for Ciliate based expression technology.
open press release (English)

 

21.06.2012 Website of the German Ministry of Economics and Technology (BMWi)
The German Ministry of Economics and Technology has selected Cilian’s completed research project for the expression of monoclonal antibodies in Ciliates as successful example for the Central Innovation Program for SMEs.
» Low risk and cost effective production of complex antibodies (German only)

 

10.10.2011 Press release
Cilian AG reached major milestone with the production and in vivo testing of recombinant flu viral protein as potential vaccine against Influenza.
open press release (English)

 

10.08.2011 Press release
Cilian AG granted two European Patents for Ciliate based expression technology.
open press release (English)

 

22.02.2011 BMC Biotechnology
Cilian publishes article in BMC Biotechnology.
„Expression, secretion and surface display of a human alkaline phosphatase by the ciliate Tetrahymena thermophila
open article (English)

 

28.01.2011 Press release
Cilian’s supervisory board appoints Christian Scheiner as CEO. Christian Scheiner will succeed Remco Brandt, who will be available for the company as consultant..
open press release (English)

 

12.01.2011 Press release
Cilian receives SME-innovation funding from the German Federal Ministry of Education and Research for the ciliate-based production of disease controlling antirheumatic drugs.
open press release (English)

 

14.09.2010 Press release
Cilian AG filed a patent application for the production of monoclonal antibodies in Ciliates.
open press release (English)

 

27.07.2010 Cilian as sponsor of the Polopicknick 2010
„Cilian sponsors this year the Polopicknick 2010, which will be taken place at 31th of July and 1st of August 2010. This traditional event, located at the gates of the City of Münster (Germany), is in all of Germany a unique tournament event. For the spectators the Polopicknick, which repeats this year seventh times, means to see spectacular sports and the impressive harmony between men and horse. A perfect frame for a relaxed and convivial get-together. Traditionally receipts will spend for a charity project.“
» www.polopicknick.de

 

04.05.2010 Press release
Cilian receives ZIM-Solo grant from the German Federal Ministry of Economy for its innovative expression system for the production of monoclonal antibodies.
open press release (English/German)

 

09.02.2010 New York Times
„Ciliates have been elected for Life-form of the Month February 2010.“
Olivia Judson, reporter and evolutionary biologist of the New York Times, explains the vote for Ciliates as the Life-form of the Month due to its excellent suitability as model organism, its unique sexual reproduction as well as unique structure of its genome.
» Read the english online article „Unorthodox“ on the web page „Opinionator“ of the New York Times.

 

22.10.2009 Press release
„Lonza acquires stake in Cilian AG“
Lonza announced today that it has signed an investment agreement, including a right of first refusal for the commercial production of products, with Cilian AG. The collaboration with Cilian provides access to a prospective technology platform for innovative applications in the nutrition and biopharmaceutical area.
open press release (English)

 

24.04.2009 WAZ – Erlebnis Münsterland
Report about Cilian AG
„Malaria will be combat in Münster“
open newspaper article (German language)

 

13.05.2008 WDR (West German Broadcasting Station) „Reports from Brussels“
Short film about Cilian AG in German language
„In the labs of Cilian, a biotech company from Muenster, Germany, microbiologist Dr. Marcus Hartmann and his team utilize the similarity of Ciliates with Malaria pathogens…“
Flash-Movie (German)

 

28.12.2007 Ruhrnachrichten
Report about Cilian AG
„Revolution from Muenster, Germany, – Scientists are developing a Malaria vaccine“
open newspaper article (German language)

 

02.06.2007 Press release
Cilian AG granted Russian Patent for lead CILIAN drug.
open press release (English)

 

30.05.2007 Press release
Cilian awarded EU grant to develop a production system for malaria vaccines. The € 1.27 million grant, which was awarded to a Cilian-led consortium of 2 leading European Universities in the field of malaria research, will finance the development of a multiple malaria-antigen vaccine.
open press release (English/German)

 

01.02.2007 Press release
Cilian AG receives grant for its innovative expression system for the production of biopharmaceutical proteins
open press release (German/English)

 

11.01.2007 Westfälische Nachrichten
Dr. Marcus Hartmann, CSO of Cilian, as ambassador for the „Aktion Münsterland“.
open press release (German)

 

07.01.2007 WDR Lokalzeit Münsterland
Short film about Cilian AG
WDR - Lokalzeit Münsterland (German)

 

23.11.2006 Münstersche Zeitung
Cilian AG in the European Parliament
Cilian, the winner of the „Innovationspreis Münsterland ´05, attends to the touring exhibition „Innovationen aus Westfalen“ with EU industry commisioner Günther Verheugen in the European Parliamentin Brussels.
„Busy ciliates – scientist from Münster produces agents against maldigestion…“
open newspaper article (German)

 

22.11.2006 Press release
Cilian AG granted European Patent for lead Cilian production platform.
open press release (English)

 

05.07.2006 Press release
Cilian AG granted Chinese Patent for lead CILIAN drug.
open press release (English)

 

16.05.2006 Press release
Cilian AG granted US Patent for lead CILIAN production platform.
open press release (English)

 

24.11.2005 Miscellaneous
Cilian wins the „Innovationspreis Münsterland 2005“
Cilian is the winner of the „Innovationspreis Münsterland 2005“ a price more than 100 companies applied for to be awarded for outstanding, innovative inventions and developments.
open press release (Westfälische Nachrichten, German)
open newspaper article (Münstersche Zeitung, German)
Innovationspreis Münsterland 2005 (German)

 

18.05.2005 Press release
Cilian AG granted European Patent for lead CILIAN drug
open newspaper article (English)

 

02.04.2004 Press release
Cilian Closes € 5 Million Series B Financing
Münster, Germany, April 02, 2004 – Cilian AG, a privately held company leveraging a novel expression system to produce recombinant proteins and therapeutic enzymes at an unmatched…
open newspaper article (English)

 

12.02.2003 Münstersche Zeitung
Niederländische Euros für Cilian AG…
Für BioTech-Firmen wird es zunehmend schwieriger, Start-Kapital zu erhalten. Dass es mit einer guten Idee doch geht, zeigt die Cilian AG…
open newspaper article (German)

 

12.02.2003 Münstersche Zeitung
Einzeller aus der Pfütze gezähmt…
Bei guten Ideen fließt auch das Risikokapital: Cilian AG Münster. In der Pfütze schwimmen die kleinen Urtierchen normalerweise durch die Gegend und fressen Bakterien…
open newspaper article (German)

 

12.02.2003 Westfälische Nachrichten
Sprung ins kalte Wasser nicht bereut…
Trotz schlechter Wirtschaftslage: Cilian AG und Implanta AG am Markt
Münster – Die angespannte Wirtschaftslage macht es jungen Unternehmen nicht gerade leicht, sich mit einem innovativen Konzept zu behaupten…
open newspaper article (German)